Literature DB >> 31571516

Pregnancy outcomes in women with primary systemic vasculitis: a retrospective study.

Vanessa Nguyen1,2, Danielle Wuebbolt1,2, Christian Pagnoux3, Rohan D'Souza1.   

Abstract

BACKGROUND/AIMS: Pregnancies in women with systemic vasculitis constitute high-risk pregnancies, and outcomes vary based on the size of the affected blood vessels. Currently, there is limited data describing pregnancy outcomes in these women. The aim of this paper is to evaluate pregnancy outcomes in women with large, medium, or small vessel vasculitis to aid preconceptional counseling and inform antepartum and intrapartum care.
METHODS: We included all women with large-, medium-, or small-vessel vasculitis and documented pregnancies attending high-risk pregnancy clinics at Mount Sinai Hospital, Toronto, Canada between 2001 and 2016. Pregnancy characteristics and outcomes were reported as proportions. Maternal, fetal/neonatal, and obstetric outcomes, stratified by type of vasculitis, were the main outcomes measured.
RESULTS: We identified 60 pregnancies in 50 women with systemic vasculitis. These included large-vessel (n = 10), medium-vessel (n = 5), small-vessel [n = 30, of which 16 were AntiNeutrophil Cytoplasmic Autoantibody (ANCA)-associated and 14 were immune-complex mediated], central nervous system (n = 3), and retinal (n = 2). Although vasculitis flares occurred with large-vessel (3/12), small-vessel (13/36), and retinal (2/3) vasculitis, only one was severe and involved hemoptysis requiring blood transfusion in a woman with ANCA-associated vasculitis. Preeclampsia complicated two pregnancies each with large- (25%) and small- (6%) vessel vasculitis. Intrauterine growth restriction (IUGR) only occurred with small-vessel vasculitis (10, 29.4%). Although seven (26.4%) viable pregnancies resulted in preterm birth, the mean gestational age was over 35 weeks.
CONCLUSION: Although women with systemic vasculitis can have successful pregnancies, they are at increased risk for late preterm birth. In addition, those with small-vessel vasculitis are at increased risk for IUGR and vasculitis flares.

Entities:  

Keywords:  Central nervous system vasculitis; large-vessel; medium-vessel; pregnancy complications; small-vessel; systemic vasculitis

Mesh:

Year:  2019        PMID: 31571516     DOI: 10.1080/14767058.2019.1671329

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

Review 1.  [New aspects of rare rheumatic diseases during pregnancy].

Authors:  Jörg Henes; Ann-Christin Pecher
Journal:  Z Rheumatol       Date:  2021-09-17       Impact factor: 1.372

Review 2.  Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.

Authors:  Ann-Christin Pecher; Melanie Henes; Joerg Christoph Henes
Journal:  Arch Gynecol Obstet       Date:  2022-09-14       Impact factor: 2.493

Review 3.  Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases.

Authors:  Silvia Cavalli; Paola Adele Lonati; Maria Gerosa; Roberto Caporali; Rolando Cimaz; Cecilia Beatrice Chighizola
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

Review 4.  A comprehensive guide for managing the reproductive health of patients with vasculitis.

Authors:  Catherine Sims; Megan E B Clowse
Journal:  Nat Rev Rheumatol       Date:  2022-10-03       Impact factor: 32.286

Review 5.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.